Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Cancer Research
|
January 1, 1982
Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule
R J Spiegel, R H Blum, M Levin, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients
N Colombo, J L Speyer, M Green, et al.
Cancer Clinical Trials
|
January 1, 1978
A therapeutic trial of maytansine
R H Blum, B K Wittenberg, G P Canellos, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Cancer Treatment Reports
|
March 1, 1986
Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional disease
R H Blum, J Cooper, A M Schmidt, et al.
Journal of Interferon Research
|
December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomas
E C Borden, K Kim, L Ryan, et al.
Cancer Treatment Reports
|
November 1, 1979
Phase I trial of bruceantin
M B Garnick, R H Blum, G P Canellos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group
P D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2000
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190
J M Kirkwood, J G Ibrahim, V K Sondak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586)
W J Tester, K M Kim, R L Krigel, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Cancer Research
|
January 1, 1982
Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule
R J Spiegel, R H Blum, M Levin, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Phase II study of carboplatin in recurrent ovarian cancer: severe hematologic toxicity in previously treated patients
N Colombo, J L Speyer, M Green, et al.
Cancer Clinical Trials
|
January 1, 1978
A therapeutic trial of maytansine
R H Blum, B K Wittenberg, G P Canellos, et al.
Cancer
|
February 1, 1983
Survival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study
K H Antman, R H Blum, R E Wilson, et al.
Cancer Treatment Reports
|
March 1, 1986
Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional disease
R H Blum, J Cooper, A M Schmidt, et al.
Journal of Interferon Research
|
December 1, 1992
Phase II trials of interferons-alpha and -beta in advanced sarcomas
E C Borden, K Kim, L Ryan, et al.
Cancer Treatment Reports
|
November 1, 1979
Phase I trial of bruceantin
M B Garnick, R H Blum, G P Canellos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1989
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group
P D Bonomi, D M Finkelstein, J C Ruckdeschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2000
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190
J M Kirkwood, J G Ibrahim, V K Sondak, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1999
A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586)
W J Tester, K M Kim, R L Krigel, et al.
Page
of 5